Michaela Murgašová1, Kamil Zeleňák2, Eva Hlaučová1, Dalibor Murgaš3, Peter Bánovčin1
The term hemangioma has traditionaly been applied to a variety of vascular lesions. True hemangiomas are the soft tissue tumors with the rapid proliferative phase of the endothelial cells in early childhood. This phase is followed by spontaneous slow involution. Vasoformative tumors can be associated with certain syndromes. Only small part of the patients – especially those with alarming hemangiomas – needs some kind of treatment. But most hemangiomas require no therapy only with close observation over their lifecycle. Therapeutical management depends on the type, on the localisation and on the volume of the lesion, on the age and on the comorbidity of the patient. It depends on the growth pattern of lesion too. Medical (beta-blockers, corticosteroids) and invasive options (surgery, embolotherapy) are available for the treatment of complicated hemangiomas. The treatment of hemangiomas is often complex and involves multiple therapeutic options. This article is concerned on the embolotherapy and the author’s experiences with it.